Diagnostics & biomarkers

Same BMI, different biology: low-cost markers may expose the obesity risk the scale misses

Parkinson’s Risk Is Not One Thing

Cardiometabolic risk leaves a protein signature in childhood. Could it guide prevention decades earlier?

HER2 Testing Just Became the Gatekeeper in Gastroesophageal Cancer

Canada Moves. Alzheimer’s Patients Still Wait.

FDA Is Asking the Right AI Question: Who Watches the Model After Approval?

Europe Made Genomics Mandatory.

Dermatophilus Changed Pattern.

C. Diff Can Hide in Plain Sight.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
